Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
Submitted by
admin
on August 26, 2013 - 9:34am
Source:
Fierce Biotech
News Tags:
MedImmune
AstraZeneca
M&A
Headline:
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
Do Not Allow Advertisers to Use My Personal information
